Additionally, WMSP enhanced the viability and suppressed cellular inflammation in Helicobacter pylori-infected GES-1 cell in vitro, with the underlying mechanism linked to the inhibition of the IL-6/STAT3 signaling pathway
Continue current management strategies and adjust as symptoms dictate
The Patient: 32-year-old, 16 weeks pregnant, with pre-existing Type 2 diabetes managed on insulin
Critically, AOD-9604 did not produce the metabolic side effects associated with full-length growth hormone, including no insulin resistance or glucose intolerance, no elevation of IGF-1 levels, no fluid retention or joint pain, and no cardiovascular parameter changes
1 If you or someone you know has type 2 diabetes, you may have heard of glucagon-like peptide-1 (GLP-1) agonist medications